Abstract:Nanozymes, possessing enzyme-like characteristics, have emerged as valuable nanomaterials in biomedical applications owing to their advantages over natural enzymes. Since nanozymes exhibit several vital and excellent catalysis activities to mediate multiple oxidation-reduction reactions that can further induce changes of cancer cells and tumor microenvironment, their applications in cancer theranostics have attracted widespread attention. Thus, this scientometric analysis aims to offer a comprehensive overview of the advancements and burgeoning trends in this field. The comprehensive assessment of scientometric analysis encompasses focal areas of inquiry, emergent research paradigms, and bibliometric profiles. The study analyzes the annual distribution of publications and citations, the geographical distribution across countries and institutions, categorizations by subject matter, contributions from academic journals, authorship patterns, and cited references. Drawing upon the findings of our scientometric evaluation coupled with an integrative review of pertinent contemporary literature, comprehensive analyses of this domain have been executed. First, the classification of nanozymes used in cancer diagnosis and treatment is reviewed. Succeeding that, various nanozyme-based approaches for both in vitro and in vivo cancer detection are outlined, supplemented by relevant examples. Subsequently, distinct nanozymebased treatment strategies are delineated, including catalytic activity-based strategies, such as ROS generation, GSH depletion, starvation therapy, oxygen supply, and TAE remodeling and immunogenic cell death, and nanostructure-based non-catalytic strategies, such as drug delivery, photodynamic and sonodynamic effects, photothermal and magnetic hyperthermia effects, prodrug activation, and ion imbalance. Finally, seven prevalent treatment modalities (catalytic therapy combined with chemodynamic therapy, immunotherapy, chemotherapy, radiotherapy, photothermal therapy or magnetic hyperthermia therapy, photodynamic therapy, and sonodynamic therapy) are categorized and elaborated on. In conclusion, this comprehensive review aims to inspire innovative research endeavors in related domains and accelerate progress in nanozyme-mediated cancer diagnostics and therapeutics.

Nanozymes for Catalytic Cancer Immunotherapy

Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy

Nanozyme: a Rising Star for Cancer Therapy.

A Bionanozyme with Ultrahigh Activity Enables Spatiotemporally Controlled Reactive Oxygen Species Generation for Cancer Therapy

Progress and prospects of nanozymes for enhanced antitumor therapy

Nanozymes with biomimetically designed properties for cancer treatment

The rational design of nanozymes for imaging-monitored cancer therapy

Deep Insight of Design, Mechanism, and Cancer Theranostic Strategy of Nanozymes

Nanozyme-based Cancer Theranostics: A Scientometric Analysis and Comprehensive Review

Multifaceted nanozymes for synergistic antitumor therapy: A review

Efficient bionic nanozyme based on AuPt NPs@ZIF-90 used for cyclic catalysis multimodal tumor therapy

Nanozyme for tumor therapy: Surface modification matters

Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes

Current Advances of Atomically Dispersed Metal-Centered Nanozymes for Tumor Diagnosis and Therapy

Application and progress of nanozymes in antitumor therapy

Transition-metal-based nanozymes for biosensing and catalytic tumor therapy

Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics

Catalytic imaging-guided cancer therapy using non-coordinated and coordinated nanozymes

Self‐Oxygenated Biomimetic Nanozyme for Tumor Catalytic Immunotherapy

A Single‐Atom Nanozyme Cascade for Selective Tumor‐Microenvironment‐Responsive Nanocatalytic Therapy

Nanozyme-based medicine for enzymatic therapy: progress and challenges